Search

everythinglearnresearchcommunity

for

Search:↓

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

SHBG may be a useful early indicator and treatment target for PCOS.

Testosterone may slow down wound healing and increase inflammation.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Mouse genital development depends on male or female hormones for specific features.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The conclusion is that understanding how feathers and hairs pattern can help in developing hair regeneration treatments.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.